Ascentage Pharma Group International (AAPG) Retained Earnings (2023 - 2024)

Ascentage Pharma Group International (AAPG) has 2 years of Retained Earnings data on record, last reported at -$803.4 million in Q4 2024.

  • For Q4 2024, Retained Earnings fell 7.81% year-over-year to -$803.4 million; the TTM value through Dec 2024 reached -$803.4 million, down 7.81%, while the annual FY2024 figure was -$803.1 million, 5.78% down from the prior year.
  • Retained Earnings reached -$803.4 million in Q4 2024 per AAPG's latest filing, down from -$745.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$745.1 million in Q4 2023 and bottomed at -$803.4 million in Q4 2024.